These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 18050150)

  • 1. Pharmaceutical expenditure, total health-care expenditure and GDP.
    Clemente J; Marcuello C; Montañés A
    Health Econ; 2008 Oct; 17(10):1187-206. PubMed ID: 18050150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the international stability of health care expenditure functions: are government and private functions similar?
    Clemente J; Marcuello C; Montañés A; Pueyo F
    J Health Econ; 2004 May; 23(3):589-613. PubMed ID: 15120472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unit root properties of OECD health care expenditure and GDP data.
    MacDonald G; Hopkins S
    Health Econ; 2002 Jun; 11(4):371-6. PubMed ID: 12007167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spending on medicines in Israel in an international context.
    Sax P
    Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The determinants of health-care expenditure: new results from semiparametric estimation.
    Herwartz H; Theilen B
    Health Econ; 2010 Aug; 19(8):964-78. PubMed ID: 19662662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The determinants of health care expenditure: testing pooling restrictions in small samples.
    Herwartz H; Theilen B
    Health Econ; 2003 Feb; 12(2):113-24. PubMed ID: 12563659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical expenditure compared across countries.
    van Mosseveld C
    Can J Clin Pharmacol; 2005; 12(3):e269-75. PubMed ID: 16373959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The convergence of health care expenditure in the US states.
    Wang Z
    Health Econ; 2009 Jan; 18(1):55-70. PubMed ID: 18273915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-country disparities in health-care expenditure: a factor decomposition.
    Alcalde-Unzu J; Ezcurra R; Pascual P
    Health Econ; 2009 Apr; 18(4):479-85. PubMed ID: 18613298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pervasiveness of pharmaceutical expenditure inertia in the OECD countries.
    Okunade AA; Suraratdecha C
    Soc Sci Med; 2006 Jul; 63(1):225-38. PubMed ID: 16459005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care expenditure and GDP: are they broken stationary?
    Carrion-i-Silvestre JL
    J Health Econ; 2005 Sep; 24(5):839-54. PubMed ID: 16129126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tests of stationarity and cointegration of health care expenditure and gross domestic product: an application to Turkey.
    Kiymaz H; Akbulut Y; Demir A
    Eur J Health Econ; 2006 Dec; 7(4):285-9. PubMed ID: 17109146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost of health care.
    Aspaas PK
    S D Med; 2006 Nov; 59(11):462. PubMed ID: 17180840
    [No Abstract]   [Full Text] [Related]  

  • 14. Reducing out-of-pocket expenditures to reduce poverty: a disaggregated analysis at rural-urban and state level in India.
    Garg CC; Karan AK
    Health Policy Plan; 2009 Mar; 24(2):116-28. PubMed ID: 19095685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical expenditures as a correlate of population health in industrialized nations.
    Liu L; Cline RR; Schondelmeyer SW; Schommer JC
    Ann Pharmacother; 2008 Mar; 42(3):368-74. PubMed ID: 18272699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aging, health expenditure, proximity to death, and income in Finland.
    Häkkinen U; Martikainen P; Noro A; Nihtilä E; Peltola M
    Health Econ Policy Law; 2008 Apr; 3(Pt 2):165-95. PubMed ID: 18634626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ANALYSIS OF TRENDS IN LIFE EXPECTANCIES AND PER CAPITA GROSS DOMESTIC PRODUCT AS WELL AS PHARMACEUTICAL AND NON-PHARMACEUTICAL HEALTHCARE EXPENDITURES.
    Hermanowski T; Bystrov V; Staszewska-Bystrova A; Szafraniec-Buryło SI; Rabczenko D; Kolasa K; Orlewska E
    Acta Pol Pharm; 2015; 72(5):1045-50. PubMed ID: 26665412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What drives health care expenditure?--Baumol's model of 'unbalanced growth' revisited.
    Hartwig J
    J Health Econ; 2008 May; 27(3):603-23. PubMed ID: 18164773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical pricing and reimbursement reforms in Greece.
    Yfantopoulos J
    Eur J Health Econ; 2008 Feb; 9(1):87-97. PubMed ID: 17619920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health expenditure and income in the United States.
    Moscone F; Tosetti E
    Health Econ; 2010 Dec; 19(12):1385-403. PubMed ID: 19842092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.